251 related articles for article (PubMed ID: 15956289)
1. Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation.
Hubbard VM; Eng JM; Ramirez-Montagut T; Tjoe KH; Muriglan SJ; Kochman AA; Terwey TH; Willis LM; Schiro R; Heller G; Murphy GF; Liu C; Alpdogan O; van den Brink MR
Blood; 2005 Nov; 106(9):3285-92. PubMed ID: 15956289
[TBL] [Abstract][Full Text] [Related]
2. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
[TBL] [Abstract][Full Text] [Related]
3. Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.
Yu XZ; Liang Y; Nurieva RI; Guo F; Anasetti C; Dong C
J Immunol; 2006 Jun; 176(12):7394-401. PubMed ID: 16751384
[TBL] [Abstract][Full Text] [Related]
4. Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target.
Sato M; Storb R; Loretz C; Stone D; Mielcarek M; Sale GE; Rezvani AR; Graves SS
Transplantation; 2013 Jul; 96(1):34-41. PubMed ID: 23694952
[TBL] [Abstract][Full Text] [Related]
5. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
6. Inducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway disease.
Tesciuba AG; Subudhi S; Rother RP; Faas SJ; Frantz AM; Elliot D; Weinstock J; Matis LA; Bluestone JA; Sperling AI
J Immunol; 2001 Aug; 167(4):1996-2003. PubMed ID: 11489981
[TBL] [Abstract][Full Text] [Related]
7. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.
Fowler DH; Gress RE
Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730
[TBL] [Abstract][Full Text] [Related]
8. Expression level of costimulatory receptor ICOS is critical for determining the polarization of helper T cell function.
Watanabe S; Ogawa S; Hara Y; Tanabe K; Toma H; Abe R
Transpl Immunol; 2006 Apr; 15(4):255-63. PubMed ID: 16635747
[TBL] [Abstract][Full Text] [Related]
9. Opposing effects of anti-activation-inducible lymphocyte-immunomodulatory molecule/inducible costimulator antibody on the development of acute versus chronic graft-versus-host disease.
Ogawa S; Nagamatsu G; Watanabe M; Watanabe S; Hayashi T; Horita S; Nitta K; Nihei H; Tezuka K; Abe R
J Immunol; 2001 Nov; 167(10):5741-8. PubMed ID: 11698447
[TBL] [Abstract][Full Text] [Related]
10. The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
Wiendl H; Neuhaus O; Mehling M; Wintterle S; Schreiner B; Mitsdoerffer M; Wienhold W; Weissert R; Wessels J; Hartung HP; Weller M; Tolosa E; Melms A
J Neuroimmunol; 2003 Jul; 140(1-2):177-87. PubMed ID: 12864987
[TBL] [Abstract][Full Text] [Related]
11. ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling.
Watanabe M; Watanabe S; Hara Y; Harada Y; Kubo M; Tanabe K; Toma H; Abe R
J Immunol; 2005 Feb; 174(4):1989-96. PubMed ID: 15699127
[TBL] [Abstract][Full Text] [Related]
12. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ
J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase-independent signaling pathways contribute to ICOS-mediated T cell costimulation in acute graft-versus-host disease in mice.
Li J; Heinrichs J; Leconte J; Haarberg K; Semple K; Liu C; Gigoux M; Kornete M; Piccirillo CA; Suh WK; Yu XZ
J Immunol; 2013 Jul; 191(1):200-7. PubMed ID: 23729441
[TBL] [Abstract][Full Text] [Related]
14. B7RP-1-ICOS interactions are required for optimal infection-induced expansion of CD4+ Th1 and Th2 responses.
Wilson EH; Zaph C; Mohrs M; Welcher A; Siu J; Artis D; Hunter CA
J Immunol; 2006 Aug; 177(4):2365-72. PubMed ID: 16887998
[TBL] [Abstract][Full Text] [Related]
15. Inducible costimulator expression regulates the magnitude of Th2-mediated airway inflammation by regulating the number of Th2 cells.
Clay BS; Shilling RA; Bandukwala HS; Moore TV; Cannon JL; Welcher AA; Weinstock JV; Sperling AI
PLoS One; 2009 Nov; 4(11):e7525. PubMed ID: 19888475
[TBL] [Abstract][Full Text] [Related]
16. Regulatory roles of IL-2 and IL-4 in H4/inducible costimulator expression on activated CD4+ T cells during Th cell development.
Yagi J; Arimura Y; Dianzani U; Uede T; Okamoto T; Uchiyama T
J Immunol; 2003 Jul; 171(2):783-94. PubMed ID: 12847246
[TBL] [Abstract][Full Text] [Related]
17. Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.
Betts BC; Bastian D; Iamsawat S; Nguyen H; Heinrichs JL; Wu Y; Daenthanasanmak A; Veerapathran A; O'Mahony A; Walton K; Reff J; Horna P; Sagatys EM; Lee MC; Singer J; Chang YJ; Liu C; Pidala J; Anasetti C; Yu XZ
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1582-1587. PubMed ID: 29382747
[TBL] [Abstract][Full Text] [Related]
18. ICOS expression by activated human Th cells is enhanced by IL-12 and IL-23: increased ICOS expression enhances the effector function of both Th1 and Th2 cells.
Wassink L; Vieira PL; Smits HH; Kingsbury GA; Coyle AJ; Kapsenberg ML; Wierenga EA
J Immunol; 2004 Aug; 173(3):1779-86. PubMed ID: 15265908
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis.
Greenwald RJ; McAdam AJ; Van der Woude D; Satoskar AR; Sharpe AH
J Immunol; 2002 Feb; 168(3):991-5. PubMed ID: 11801630
[TBL] [Abstract][Full Text] [Related]
20. Inducible costimulator: a modulator of IFN-gamma production in human tuberculosis.
Quiroga MF; Pasquinelli V; Martínez GJ; Jurado JO; Zorrilla LC; Musella RM; Abbate E; Sieling PA; García VE
J Immunol; 2006 May; 176(10):5965-74. PubMed ID: 16670305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
